JPS5929622A
(ja)
*
|
1982-08-10 |
1984-02-16 |
Meiji Seika Kaisha Ltd |
モノクロ−ナル抗体、その製造法およびその用途
|
US5179018A
(en)
*
|
1983-10-14 |
1993-01-12 |
Centocor, Inc. |
Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
|
US4617264A
(en)
*
|
1983-11-04 |
1986-10-14 |
Syntex (U.S.A.) Inc. |
Pretreatment method and composition
|
US4722903A
(en)
*
|
1983-11-14 |
1988-02-02 |
New York Blood Center, Inc. |
Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
|
US4851334A
(en)
*
|
1984-01-03 |
1989-07-25 |
The New York Blood Center, Inc. |
Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fibrin I or human fibrin II
|
DK219084D0
(da)
*
|
1984-05-02 |
1984-05-02 |
Frederik Carl Peter Lindberg |
Antigen
|
GB8416840D0
(en)
*
|
1984-07-03 |
1984-08-08 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8416843D0
(en)
*
|
1984-07-03 |
1984-08-08 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8416844D0
(en)
*
|
1984-07-03 |
1984-08-08 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8416845D0
(en)
*
|
1984-07-03 |
1984-08-08 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8416842D0
(en)
*
|
1984-07-03 |
1984-08-08 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8416841D0
(en)
*
|
1984-07-03 |
1984-08-08 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8422650D0
(en)
*
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8422651D0
(en)
*
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8422652D0
(en)
*
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8422649D0
(en)
*
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
GB8422653D0
(en)
*
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
US4677070A
(en)
*
|
1985-04-26 |
1987-06-30 |
Cetus Corporation |
Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
|
US6365368B1
(en)
*
|
1985-05-10 |
2002-04-02 |
Igen International, Inc. |
Rapid method for the detection and quantification of microbes in water
|
GB8517895D0
(en)
*
|
1985-07-16 |
1985-08-21 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
EP0209493A3
(en)
*
|
1985-07-16 |
1988-05-04 |
Ciba-Geigy Ag |
Prophylaxis and treatment of whooping cough
|
US4772464A
(en)
*
|
1985-08-01 |
1988-09-20 |
Miles Laboratories, Inc. |
Protective antibodies to serotypic determinants of flagellar antigens
|
EP0211352B1
(en)
*
|
1985-08-01 |
1994-03-16 |
Miles Inc. |
Protective antibodies to serotypic determinants of flagellar antigens
|
US4784850A
(en)
*
|
1985-09-04 |
1988-11-15 |
Mutzarei Maabarot |
Process for preparing antibodies against E. Coli K-99 antigen from bovine milk
|
US4918163A
(en)
*
|
1985-09-27 |
1990-04-17 |
Pfizer Inc. |
Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
|
US4772551A
(en)
*
|
1985-12-26 |
1988-09-20 |
Neogen Corporation |
Method and test kit for detecting a trichothecene using novel monoclonal antibodies
|
AU7202887A
(en)
*
|
1986-03-26 |
1987-10-20 |
Murex Corp. |
Device and method for determining microbial resistance to antimicrobic agents
|
ES2009365A6
(es)
*
|
1986-04-24 |
1989-09-16 |
Univ California |
Procedimiento de otencion de anticuerpos monoclonales para bacterias gram-negativas.
|
US4834976A
(en)
*
|
1986-07-03 |
1989-05-30 |
Genetic Systems Corporation |
Monoclonal antibodies to pseudomonas aeruginosa flagella
|
US5300425A
(en)
*
|
1987-10-13 |
1994-04-05 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5217869A
(en)
*
|
1987-10-13 |
1993-06-08 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5055455A
(en)
*
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
GB8826116D0
(en)
*
|
1988-11-08 |
1988-12-14 |
Danbiosyst Ltd |
Adhesive drug delivery composition
|
US5350771A
(en)
*
|
1989-03-22 |
1994-09-27 |
Peter K. T. Pang |
Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
|
US5886012A
(en)
*
|
1989-03-22 |
1999-03-23 |
Peter K. T. Pang |
Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
|
JP2919607B2
(ja)
*
|
1989-03-22 |
1999-07-12 |
ピーター ケー テイー パング |
パラシロイド高血圧性因子
|
CA1340530C
(en)
*
|
1989-04-28 |
1999-05-04 |
Kok Kheong Lee |
Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
|
WO1992001703A1
(en)
*
|
1990-07-24 |
1992-02-06 |
Emory University |
Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes
|
CA2161404A1
(en)
*
|
1993-04-26 |
1994-11-10 |
William W. Kay |
Methods and compositions for salmonella-based vaccines
|
US7118758B1
(en)
|
1997-01-24 |
2006-10-10 |
The United States Of America As Represented By The Secretary Of The Army |
Transformed bacteria producing CS6 antigens as vaccines
|
US5798260A
(en)
*
|
1994-06-24 |
1998-08-25 |
Children's Hospital And Medical Center |
Escherichia coli O157:H7 epithelial adhesin
|
US6046037A
(en)
*
|
1994-12-30 |
2000-04-04 |
Hiatt; Andrew C. |
Method for producing immunoglobulins containing protection proteins in plants and their use
|
AU722668B2
(en)
|
1994-12-30 |
2000-08-10 |
King's College London |
Methods for producing immunoglobulins containing protection proteins in plants and their use
|
US6808709B1
(en)
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
US5914114A
(en)
*
|
1995-06-02 |
1999-06-22 |
The United States Of America As Represented By The Secretary Of The Army |
Method of raising antibodies against E. coli of the family CS4-CFA/I
|
US7252828B2
(en)
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
US20030170823A1
(en)
|
1999-12-23 |
2003-09-11 |
Presnell Scott R. |
Novel cytokine ZCYTO18
|
US7207898B2
(en)
*
|
2000-04-18 |
2007-04-24 |
Acushnet Company |
Metal wood club with improved hitting face
|
US7041003B2
(en)
*
|
2000-04-18 |
2006-05-09 |
Acushnet Company |
Golf club head with variable flexural stiffness for controlled ball flight and trajectory
|
US7704162B2
(en)
*
|
2000-04-18 |
2010-04-27 |
Acushnet Company |
Metal wood club with improved hitting face
|
US7029403B2
(en)
*
|
2000-04-18 |
2006-04-18 |
Acushnet Company |
Metal wood club with improved hitting face
|
US7261643B2
(en)
*
|
2000-04-18 |
2007-08-28 |
Acushnet Company |
Metal wood club with improved hitting face
|
US7935001B2
(en)
*
|
2000-04-18 |
2011-05-03 |
Acushnet Company |
Composite metal wood club
|
US7682262B2
(en)
*
|
2000-04-18 |
2010-03-23 |
Acushnet Company |
Metal wood club with improved hitting face
|
US7214142B2
(en)
*
|
2000-04-18 |
2007-05-08 |
Acushnet Company |
Composite metal wood club
|
US20060015969A1
(en)
*
|
2000-04-28 |
2006-01-19 |
Planet Biotechnology, Inc. |
Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
|
DK1290027T3
(da)
*
|
2000-04-28 |
2010-01-18 |
Planet Biotechnology Inc |
Immunoadhæsin til forebyggelse af rhinovirusinfektion
|
FR2822834B1
(fr)
*
|
2001-04-02 |
2005-02-25 |
Flamel Tech Sa |
Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
|
FR2830447B1
(fr)
*
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
US20070118934A1
(en)
*
|
2001-10-26 |
2007-05-24 |
Planet Biotechnology, Inc. |
Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
|
WO2003080082A1
(en)
*
|
2002-03-21 |
2003-10-02 |
Anadis Ltd |
Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
|
US7265211B2
(en)
|
2002-03-22 |
2007-09-04 |
Zymogenetics, Inc. |
Anti-IL-TIF antibodies and methods of making
|
CN100553625C
(zh)
|
2002-04-09 |
2009-10-28 |
弗拉梅技术公司 |
活性成分微囊的口服混悬液
|
KR20050005437A
(ko)
*
|
2002-04-09 |
2005-01-13 |
플라멜 테크놀로지스 |
아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
|
FR2843117B1
(fr)
*
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
CA2411508A1
(en)
*
|
2002-09-30 |
2004-03-30 |
Tony Romeo |
Methods for polysaccharide adhesin synthesis modulation
|
WO2004043407A2
(en)
*
|
2002-11-12 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
MXPA05005045A
(es)
|
2002-11-12 |
2005-07-01 |
Brigham & Womens Hospital |
Vacuna de polisacarido para infecciones estafilococicas.
|
AU2003281988B2
(en)
*
|
2002-11-25 |
2008-06-12 |
University Of Copenhagen |
Porcine polymorphisms and methods for detecting them
|
US8342982B2
(en)
*
|
2003-05-01 |
2013-01-01 |
Acushnet Company |
Metal wood club with improved hitting face
|
FR2860516B1
(fr)
*
|
2003-10-03 |
2006-01-13 |
Flamel Tech Sa |
Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
EP2455400B1
(en)
|
2004-04-21 |
2019-03-20 |
The Brigham and Women's Hospital, Inc. |
Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
|
US7549934B2
(en)
*
|
2005-09-07 |
2009-06-23 |
Acushnet Company |
Metal wood club with improved hitting face
|
US8439769B2
(en)
*
|
2005-09-07 |
2013-05-14 |
Acushnet Company |
Metal wood club with improved hitting face
|
KR20110031393A
(ko)
|
2008-07-21 |
2011-03-25 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
|
WO2020163512A1
(en)
|
2019-02-05 |
2020-08-13 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide compositions for use in treating filariasis
|